International Clinical Trial: Twelve weeks, randomized, double-blind, placebo-controlled clinical trial to evaluate efficacy and safety for improving triglyceride improvement of USCP-SL22

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (KCT0012338) titled 'Twelve weeks, randomized, double-blind, placebo-controlled clinical trial to evaluate efficacy and safety for improving triglyceride improvement of USCP-SL22' on July 27.

Study Type: Interventional Study

Study Design: Primary Purpose : Other(Health Functional Food), Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT

Primary Sponsor: Uscare Pharm

Condition:

Endocrine, nutritional and metabolic diseases

Intervention: Dietary Supplement : Subjects are randomly assigned to one of the two groups and take test and control foods twice a day (morning and e...